Adicet Bio, Inc.
NASDAQ:ACET · NASDAQ Global Market
+$0.50 today
Vol 0.08M · Avg 0.12M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
-27.88%
Period High
$16.64
Period Low
$6.11
Latest
$7.76
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Immunic, Inc.
NASDAQ:IMUX
$136.78M
Adagene Inc.
NASDAQ:ADAG
$134.41M
Gain Therapeutics, Inc.
NASDAQ:GANX
$71.66M
NRx Pharmaceuticals, Inc.
NASDAQ:NRXP
$66.38M
TScan Therapeutics, Inc.
NASDAQ:TCRX
$55.71M
Acrivon Therapeutics, Inc. Common Stock
ACRV
$46.70M
Lite Strategy, Inc.
LITS
$25.22M
CervoMed Inc.
CRVO
$22.68M
Werewolf Therapeutics, Inc.
HOWL
$18.52M
IO Biotech, Inc.
IOBT
$885,690.00
What is the latest ACET filing?
The latest filing shown is 10-K/A dated May 20, 2026.
How many recent filings does ACET have?
Intrinsic Alpha currently shows 20 recent filings for ACET.
Explore More
Continue the stock analysis
Jump to another research area for this company.